SCHEMBL32686478

SCHEMBL32686478

O=Cc1cc(Cl)c2c(c1)C(=O)NC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.37
▸ CLK1 P49759 1/20 0.36
▸ CLK2 P49760 1/20 0.36
▸ CLK3 P49761 1/20 0.36
▸ CDK5 Q00535 2/20 0.35
▸ DYRK1A Q13627 2/20 0.35
▸ CLK4 Q9HAZ1 2/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ CSNK1A1 P48729 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ DYRK1B Q9Y463 1/20 0.35
▸ KDR P35968 3/20 0.35
▸ MST1R Q04912 2/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ NTRK1 P04629 1/20 0.35
▸ MET P08581 1/20 0.35
▸ FGFR1 P11362 1/20 0.35
▸ PRKACA P17612 1/20 0.35
▸ MAP2K2 P36507 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686477 0.85 CLK1 (0.35) CLK1CLK2CLK3CDK5DYRK1A
SCHEMBL27086356 0.81 GRM2 (0.42) ALDH1A1CDK5DYRK1ACLK4PIM1
SCHEMBL30004086 0.81 GRM2 (0.42) ALDH1A1CDK5DYRK1ACLK4PIM1
SCHEMBL25415363 0.79 CDK5 (0.50) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL30598935 0.79 CDK5 (0.50) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL11346836 0.78 MEN1 (0.44) CLK1CLK2CLK3CDK5DYRK1A
SCHEMBL29920437 0.76 ALDH1A1 (0.42) ALDH1A1PIM1KDRGSK3BALDH1A3
SCHEMBL30598890 0.76 GRM2 (0.35) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL21200740 0.76 GRM2 (0.35) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL30605858 0.76 GRM2 (0.38) CDK5DYRK1ACLK4PIM1CSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709718-A1 6-SUBSTITUTED-3-PHENYL-ISOINDOLIN-1-ONES AS CBL-B INHIBITORS SELECTIVE OVER C-CBL Genentech Inc. (US) 2026-03-18 — — EP disclosed
Send feedback